DataMEDS AI Inc.
MEDS | NASDAQ
$2.00
+$0.08 (+4.17%)
Nov 2, 2026, 10:08 AM ET · Market open
Market Data
Market Cap $8.96M
Enterprise Value $38.79M
Beta -1.52
Average Volume 4.62M
Shares Outstanding (Diluted) 2.57M
Shares Change YoY 108.4%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US9495032057
Price Performance
Price Change 1M -45.6%
Price Change 3M -38.3%
Price Change 6M -61.5%
Price Change YTD -90.0%
Price Change 1Y -94.0%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -48.9%
1Y CAGR (ann.) -93.8%
5Y CAGR (ann.) -48.2%
All-Time CAGR -29.4%
Valuation
PE Ratio -0.04
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio 1.08
Forward PS N/A
PB Ratio -0.44
P/FCF Ratio -0.63
P/Adj. FCF Ratio -0.20
P/OCF Ratio -0.36
EV/Sales 4.83
EV/EBIT -0.66
EV/EBITDA -0.69
EV/FCF -2.86
Earnings Yield -2454.7%
FCF Yield -157.5%
Adj. FCF Yield -489.7%
Financial Health
Net Debt $30.17M
Total Debt $32.62M
Cash & Short-Term Investments $2.46M
Total Assets $32.76M
Current Ratio 0.14
Quick Ratio 0.10
Debt / Equity Ratio -1.67
Debt / EBITDA -0.58
Debt / FCF -2.40
OCF / Debt -0.42
Interest Coverage -9.72
Altman Z-Score -12.67
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -125.1%
Operating Profit Margin -719.3%
EBITDA Margin -703.1%
Net Profit Margin -1100.3%
FCF Margin -169.3%
Adj. FCF Margin -526.4%
SBC / Revenue 357.1%
SBC Impact (per share) -210.9%
Returns
Return on Assets -269.5%
Return on Equity 877.6%
Return on Invested Capital -439.9%
Return on Capital Employed 867.2%
Return on Tangible Assets -990.9%
Historical Growth (CAGR)
Revenue CAGR 3Y -68.8%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -44.5%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -123.0%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 17, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-13.74M
Free Cash Flow $-13.59M
Adj. Free Cash Flow $-42.23M
FCF Per Share -$5.28
OCF Per Share -$5.34
OCF/S Ratio -171.2%
Income Statement
Revenue $8.02M
Gross Profit $-10.04M
Operating Income $-57.71M
EBITDA $-56.41M
Net Income $-88.28M
EPS (Diluted) -$47.13
Revenue / Employee $258.81K
Profit / Employee $-2.85M
Employees 31
Add to Watchlist
Select watchlists to add or remove MEDS